BigSur Wealth Management LLC Acquires 2,030 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

BigSur Wealth Management LLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 32.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,250 shares of the financial services provider’s stock after acquiring an additional 2,030 shares during the period. BigSur Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,055,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Guardian Wealth Advisors LLC NC lifted its holdings in shares of iShares Biotechnology ETF by 24.8% in the 4th quarter. Guardian Wealth Advisors LLC NC now owns 372 shares of the financial services provider’s stock worth $49,000 after acquiring an additional 74 shares during the last quarter. Ally Invest Advisors Inc. lifted its holdings in shares of iShares Biotechnology ETF by 5.3% in the 4th quarter. Ally Invest Advisors Inc. now owns 1,515 shares of the financial services provider’s stock worth $200,000 after acquiring an additional 76 shares during the last quarter. Arete Wealth Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 4.2% in the 4th quarter. Arete Wealth Advisors LLC now owns 1,990 shares of the financial services provider’s stock worth $263,000 after acquiring an additional 80 shares during the last quarter. TD Private Client Wealth LLC lifted its holdings in shares of iShares Biotechnology ETF by 3.0% in the 4th quarter. TD Private Client Wealth LLC now owns 2,746 shares of the financial services provider’s stock worth $363,000 after acquiring an additional 81 shares during the last quarter. Finally, Cullen Frost Bankers Inc. lifted its holdings in shares of iShares Biotechnology ETF by 1.5% in the 4th quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock worth $748,000 after acquiring an additional 82 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.8%

iShares Biotechnology ETF stock opened at $128.00 on Friday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $150.57. The firm has a 50-day moving average price of $121.95 and a 200-day moving average price of $130.48. The firm has a market capitalization of $5.60 billion, a PE ratio of 23.96 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were issued a dividend of $0.1212 per share. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.